All In Biotech

Drug Trial Radar · NCT06445946

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

DECIDE: A Comparative Effectiveness Trial of Oral Metformin Versus Injectable Insulin for the Treatment of Gestational Diabetes

Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 1,572 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,572

Planned (sponsor's estimate)

Start

Aug 1, 2024

Primary completion

Dec 2029

Study completion Dec 2030

Sponsor

Lead sponsor
Ohio State UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Patient-Centered Outcomes Research Institute; The George Washington University Biostatistics Center
First posted
Jun 6, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a non-inferiority patient-centered and pragmatic comparative-effectiveness pregnancy randomized controlled trial (RCT) with postpartum maternal and child follow-up through 2 years of 1,572 individuals with gestational diabetes mellitus (GDM) randomized to oral metformin versus injectable insulin. This study will determine if metformin is not inferior to insulin in reducing adverse pregnancy outcomes, is comparably safe for exposed individuals and children, and if patient-reported factors, including facilitators of and barriers to use, differ between metformin and insulin. A total of 1,572 pregnant individuals with GDM who need pharmacotherapy will be recruited at 20 U.S. sites using consistent treatment criteria to metformin versus insulin. Participants and their children will be followed through delivery to two years postpartum.

Conditions

  • Gestational Diabetes Mellitus
  • Pregnancy, High Risk

Interventions

  • MetforminDrug

    Individuals randomized to this arm will receive oral metformin tablets for their Gestational diabetes mellitus treatment.

  • InsulinDrug

    Individuals randomized to this arm will receive injectable insulin for their Gestational diabetes mellitus treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A neonatal composite adverse outcome of large-for-gestational-age (LGA) birthweight, hypoglycemia, hyperbilirubinemia, and/or death.Time frame: LGA at birth. Hypoglycemia <24 hours after birth. Hyperbilirubinemia within the first week after birth. Death between randomization to hospital discharge or 30 days postnatal.
  2. Child body mass index (BMI) at 2 years of ageTime frame: 2 years of age.

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama

    Tuscaloosa, Alabama · Recruiting

  • Cedars Sinai Medical Center

    Los Angeles, California · Recruiting

  • University of California San Francisco

    San Francisco, California · Recruiting

  • Yale School of Medicine

    New Haven, Connecticut · Recruiting

  • Christiana Care

    Newark, Delaware · Withdrawn

  • University of South Florida

    Tampa, Florida · Recruiting

  • Tufts University

    Boston, Massachusetts · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Terminated

  • Washington University in St. Louis

    St Louis, Missouri · Recruiting

  • University of New Mexico

    Albuquerque, New Mexico · Recruiting

  • Columbia University Irving Medical Center

    New York, New York · Recruiting

  • University of North Caroline

    Chapel Hill, North Carolina · Withdrawn

  • Wake Forest University

    Winston-Salem, North Carolina · Recruiting

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine

    Columbus, Ohio · Recruiting

  • Premier Health - Miami Valley Hospital

    Dayton, Ohio · Recruiting

  • Kettering Health

    Kettering, Ohio · Not yet recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • University of Pittsburgh

    Pittsburgh, Pennsylvania · Recruiting

  • Brown University

    Providence, Rhode Island · Recruiting

  • University of South Carolina Greenville

    Greenville, South Carolina · Recruiting

  • University of Texas Austin

    Austin, Texas · Recruiting

  • Austin Maternal Fetal Medicine

    Austin, Texas · Recruiting

  • University of Texas Health Science Center

    Houston, Texas · Recruiting

  • Eastern Virginia Medical School - Old Dominion University

    Norfolk, Virginia · Recruiting

  • Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.